Literature DB >> 14779046

A pleuropneumonia-like organism in primary fusospirochetal gangrene of the penis.

M RUITER, H M M WENTHOLT.   

Abstract

Entities:  

Keywords:  BALANITIS

Mesh：

Year:  1950        PMID： 14779046     DOI： 10.1038/jid.1950.104

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN： 0022-202X            Impact factor:   8.551


× No keyword cloud information.
  7 in total

1.  [Pleuropneumonia-like organisms in skin flora in various dermatoses].

Authors:  N MELCZER; P VASARHELYI
Journal:  Arch Klin Exp Dermatol       Date:  1958

2.  [Pleuropneumonia-like organisms; the behavior in egg culture and resistance tests].

Authors:  T NASEMANN; H ROCKL; O HUBER
Journal:  Klin Wochenschr       Date:  1954-08-15

3.  Mycoplasma fermentans and TNF-beta interact to amplify immune-modulating cytokines in human lung fibroblasts.

Authors:  James P Fabisiak; Fei Gao; Robyn G Thomson; Robert M Strieter; Simon C Watkins; James H Dauber
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2006-06-02       Impact factor: 5.464

4.  Prevalence of pleuropneumonia-like organisms and the evaluation of media and methods for their isolation from clinical material.

Authors:  H E MORTON; P F SMITH; R KELLER
Journal:  Am J Public Health Nations Health       Date:  1952-08

5.  A 4.1-kilodalton polypeptide in the cultural supernatant of Mycoplasma fermentans is one of the substances responsible for induction of interleukin-6 production by human gingival fibroblasts.

Authors:  A Hasebe; K Shibata; T Watanabe
Journal:  Infect Immun       Date:  2001-11       Impact factor: 3.441

6.  Microbial stimulation by Mycoplasma fermentans synergistically amplifies IL-6 release by human lung fibroblasts in response to residual oil fly ash (ROFA) and nickel.

Authors:  Fei Gao; Aaron Barchowsky; Antonia A Nemec; James P Fabisiak
Journal:  Toxicol Sci       Date:  2004-06-30       Impact factor: 4.849

7.  Protein and antigen heterogeneity among strains of Mycoplasma fermentans.

Authors:  C T Städtlander; C Zuhua; H L Watson; G H Cassell
Journal:  Infect Immun       Date:  1991-09       Impact factor: 3.441
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.